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Abstract
OBJECTIVES: Stent graft-induced retrograde type A dissection is a life-threatening complication after endovascular treatment of acute
aortic type B dissections.
METHODS: From August 2005 to February 2011, retrograde aortic dissection occurred in 4 of 29 patients (13.8%) undergoing thoracic
endovascular aortic repair (TEVAR) for acute complicated aortic type B dissection. Three patients underwent emergent surgical conver-
sion immediately after TEVAR. The operative strategy was a combined surgical and endovascular approach (frozen elephant trunk tech-
nique) using a specially designed hybrid prosthesis ( Jotec E-vita open). All operations were performed under moderate hypothermia
(25–28°C) and selective bilateral antegrade cerebral perfusion. The mean duration of circulatory arrest was 56 ± 7 min. Operative data
and the outcome of surgery were analysed retrospectively. Data were analysed retrospectively in the limited number of patients.
RESULTS: All patients survived the surgical procedure. No stroke, paraplegia, renal failure or other major complications occurred.
Postoperative CT scans revealed perigraft thrombus formation and stable aortic dimensions in all patients after 6 months. In one
patient, the retrograde dissection remained primarily undetected and untreated. The patient died suddenly, with no clinical signs,
within 7 days after stent graft implantation. Autopsy revealed cardiac tamponade due to retrograde type A aortic dissection.
CONCLUSIONS: Retrograde aortic dissection type A is a serious complication of thoracic endovascular repair of acute aortic type B dis-
section. Despite the small number of patients investigated in this study, the frozen elephant trunk technique appears to be a feasible
bail-out strategy for the treatment of these acute aortic events.
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INTRODUCTION
Thoracic endovascular aortic repair (TEVAR) is used increasingly
often as a less invasive treatment option than open surgery for
patients with complicated Stanford type B thoracic aortic dissec-
tions. A complicated type B aortic dissection is deﬁned as pro-
gression of the dissection and rapid aortic dilatation with the risk
of aortic rupture, malperfusion due to compression of major ar-
terial side branches which may affect lower extremities as well as
visceral organs, refractory hypertension and pain [1].
Owing to its safety and efﬁcacy, TEVAR has become the stand-
ard procedure for complicated type B dissection [2, 3].
The potential beneﬁts of TEVAR, such as avoidance of thora-
cotomy, extracorporeal circulation and cardiac ischaemia, have
to be weighed against the considerable risk of acute or delayed
retrograde type A dissection, stroke, paraplegia or access-related
complications at the femoral or iliac arteries. Another major
concern associated with this minimally invasive procedure is
whether the stiff stent graft or endovascular manipulation would
injure the aorta. This may lead to the potentially lethal complica-
tion of retrograde ascending aortic dissection [4–12].
The aim of this retrospective analysis was to report the inci-
dence and clinical characteristics of retrograde aortic type A dis-
sections after TEVAR, and describe a bail-out strategy using the




We performed a retrospective analysis of 29 consecutive patients
who underwent TEVAR for acute complicated aortic dissection
type B from August 2005 to February 2011.
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Indications for TEVAR were malperfusion in 5 patients, con-
tained rupture in 5 patients, increasing diameter of the aorta in
4 patients and persistent pain or uncontrollable hypertension in
15 patients. The median interval between the onset of symptoms
and implantation of the endovascular graft was 4 days (range, 0–
14 days). All patients underwent CT angiography of the entire
aorta prior to the intervention in order to determine their ana-
tomical feasibility for stent graft implantation. Furthermore,
lumen diameters of the ascending aorta, the aortic arch and the
descending aorta as well as the site of the primary entry tear
were analysed.
Four patients [two men and two women; median age 62 years
(age range, 51–70 years)] developed retrograde type A
dissection.
In a 70-year old man, the retrograde dissection remained pri-
marily undetected and untreated. The patient was in hospital
with no clinical signs of rupture until Day 7 after stent graft im-
plantation. A CT-angiography was planned on this speciﬁc day to
evaluate the positioning of the stent graft and potential endo-
leaks. The patient died suddenly, with no clinical signs, 7 days
after stent graft implantation. Autopsy revealed cardiac tampon-
ade due to retrograde type A aortic dissection.
Stent graft devices
Four types of stent grafts were used in this series. The Valiant
Thoracic Stent Graft (Medtronic Endovascular, Santa Rosa, CA,
USA) was used in 21 patients. The Gore Thoracic Excluder stent
graft (WL Gore, Flagstaff, AZ, USA) was inserted in ﬁve patients.
The E-vita thoracic stent graft ( Jotec Company, Hechingen,
Germany) was used in three patients. The diameter of the stent
graft was oversized by 0–10% in relation to the diameter of the
native aorta in order to achieve tight sealing. Balloon dilatation
was avoided in all patients. All procedures were performed in
the angio suite in cooperation with, and in the presence of, an
interventional radiologist together with a cardiovascular surgeon.
All patients were operated under general anaesthesia, tracheal
intubation and mechanical ventilation.
An angiography catheter was introduced by the Seldinger
technique through the main access artery and from the contra-
lateral groin percutaneously. A maximum dose of 5000 IU
heparin was administered by the intravenous route. The angiog-
raphy catheter was advanced to the ascending aorta under
ﬂuoroscopic guidance, the delivery system was positioned at the
desired level and the stent graft deployed. In 18 patients (62%)
the origin of the left subclavian artery was covered with
the stent graft in order to satisfactorily exclude the lesion.
A ﬁnal aortography was performed to demonstrate stent graft
location and ensure that the false aneurysm had been properly
excluded.
Operative strategy of retrograde type A dissection
after TEVAR with E-vita open stent graft
In cases of retrograde aortic type A dissection (Fig. 1), we per-
formed combined surgical and endovascular repair using a spe-
cially designed hybrid prosthesis ( Jotec E-vita open).
Replacement of the ascending aorta, the aortic arch and the
proximal descending aorta can be performed simultaneously by
this combined single-session procedure.
The E-vita open hybrid device is composed of a vascular
Dacron prosthesis in continuity with the self-expanding stent
graft.
The arterial cannulation site was the right axillary artery via a
short 8-mm Dacron prosthesis. Venous cannulation was intro-
duced into the right atrium in the usual manner. All operations
were performed under moderate hypothermia (25–28°C).
Once a core temperature of 25°C had been achieved, the
ascending aorta and the concave portion of the aortic arch were
resected in a state of circulatory arrest. Selective antegrade cere-
bral perfusion with 10 ml/kg/min cold blood was achieved via a
catheter in the left carotid artery and the cannula in the right ax-
illary artery after clamping the brachiocephalic artery. Oxygen
saturation was measured by infrared spectroscopy during cere-
bral perfusion. In one patient, the previously implanted stent
graft could be extracted and removed easily from the descend-
ing aorta. In the remaining two patients the endovascular pros-
thesis already in place at the descending aorta was shortened as
far as possible.
As the next step, the E-vita open stent graft was introduced
into the true lumen of the descending aorta or the remaining
stent graft via the open aortic arch (Fig. 2). The point of orienta-
tion for placement of the stent was offspring of the subclavian
artery. After antegrade implantation through the opened aortic
arch into the descending aorta, the stent graft was ﬁxed to the
aortic stump at the origin of the left subclavian artery using a
continuous polypropylene suture supported with Teﬂon strips by
a double-sandwich technique.
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Reconstruction of the aortic arch with preservation of the
supra-aortic branches and the convex portion of the aortic arch
was performed. The ascending aorta and the concave portion of
the aortic arch were replaced with an additional coated Dacron
prosthesis and anastomosed to the reconstructed descending
aorta [13, 14]. The proximal anastomosis was performed at the
sino-tubular junction preserving the aortic valve.
RESULTS
In three patients, the retrograde dissection was observed during
the endovascular intervention in the angio suite. They were im-
mediately transferred to the operating room for emergent surgi-
cal conversion. All of these patients underwent combined
surgical and endovascular repair of the affected aorta by the
frozen elephant technique as described earlier [13, 14]. Operative
data are listed in Table 1.
A valiant stent graft prosthesis was used in all three patients
with retrograde type A aortic dissection. The site of the primary
entry tear was at the concavity of the distal aortic arch in two
patients, and at the convexity in one patient. In one patient who
experienced retrograde-type dissection (median 44 vs. 37 mm),
the diameter of the ascending aorta was remarkably larger and
the distance from the primary entry tear to the left subclavian
artery was shorter (median 9 vs. 15 mm) (Table 2).
Operative data
The mean duration of circulatory arrest was 61 ± 3 min. The dur-
ation of aortic cross-clamping and extracorporeal circulation was
92 ± 16 and 180 ± 27 min, respectively. Ventilation time was 2 ± 3
days, the stay at the intensive care unit 10 ± 8 days and the
length of hospital stay 17 ± 15 days.
Clinical outcome
All patients survived the surgical procedure. No stroke, paraple-
gia or other major neurological complications occurred. One
patient developed renal failure requiring haemoﬁltration for 8
days. Postoperative CT scans revealed perigraft thrombus forma-
tion and stable aortic dimensions in all patients after 6 months.
DISCUSSION
The technical feasibility and the low mortality and morbidity
rates of TEVAR when compared with open surgical repair for the
treatment complicated type B aortic dissection have been
reported by several authors [2, 3, 15]. However, this endovascular
intervention is not entirely devoid of risks. An increasing number
of complications of endovascular therapy have been reported in
the recent published literature [4–12].
Figure 2: The E-vita open stent graft is introduced into the remaining stent
graft located in the descending aorta via the open aortic arch.
Table 1: Descriptive characteristics of operated patients
after rTAA
n, overall = 3
Demographics
Age, mean (SD), years 58 (±7)
Male, n (%) 1 (33%)
Operative data
Extracorporeal circulation time (min) 180 (±27)
Aortic cross-clamp time (min) 92 (±16)
Circulatory arrest time (min) 61(±3)
Total operation time (min) 330 (±125)
Postoperative ventilation time (days) 2 (±3)
Duration intensive care unit stay (days) 10 (±8)
Length of hospital stay (days) 17 (±15)
Unless otherwise indicated, data are number (percentage) (± standard
deviation).








Distance to subclavian artery (mm),
mean ± SD
15 ± 4.9 9 ± 4.1
Diameter descending aorta (mm),
mean ± SD
37 ± 4.1 37 ± 5.5
True lumen diameter (mm),
mean ± SD
17 ± 2.7 23 ± 1.5
False lumen diameter (mm),
mean ± SD
20 ± 5.4 14 ± 7
Diameter abdominal aorta (mm),
mean ± SD
30 ± 5.5 41 ± 5.2
Diameter ascending aorta (mm),
mean ± SD
37 ± 3.5 44 ± 2.5
MSCT: multislice computed tomography; SD: standard deviation.
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The underlying pathology of type B aortic dissection is a sys-
temic illness. The natural progression of this aortic pathology, in-
cluding expansion of the false lumen and the diameter of the
aorta followed by further extension of the dissection or even
rupture, has been observed in one-third of patients who under-
went initial treatment 5 years after the condition was diagnosed
[16, 17].
The life-threatening situation of retrograde type A aortic dis-
section after TEVAR is caused by stent-related manipulation and
the fragility of the entire aortic wall [15].
One of the sources of potential injury to the aortic wall are
the proximal bare springs which are designed to provide strong
radial force and ensure proximal ﬁxation of the stent graft.
Retrograde type A dissections are most commonly caused by
endovascular prostheses with proximal bare springs. [6, 10, 15,
18]. Balloon dilatation bears the additional risk of a patient devel-
oping further dissection in the fragile aortic wall [12, 15, 19].
In our series, a prosthesis with a proximal bare spring was
used in 25 patients. The tip of the proximal bare springs induced
a retrograde type A dissection in four patients. In the present
series, we performed no balloon inﬂation on the dissected wall
during placement of the stent graft.
The location of the primary entry tear inﬂuences retrograde
type A dissection in acute type B dissections. In an experimental
circulatory model, Dziodzio et al. [20] described retrograde
propagation of the dissecting membranes when the primary
entry tear was located at the concavity. The same has been
reported for intramural haematoma. In contrast to the site of
convexity, the site of concavity is devoid of anatomical barriers
such as supra-aortic vessels [21].
In the recent cohort, the majority of patients experiencing
retrograde dissection after TEVAR had a primary entry tear at the
concavity of the distal aortic arch.
The shape and diameter of the ascending aorta must be taken
into account in the treatment of complicated type B dissections.
The dissection may not be limited to the descending aorta, but
may involve the ascending aorta as well due to generalized
propagation of this disease. Therefore, assessment of the ascend-
ing aorta is of substantial importance in planning effective and
safe treatment of complicated type B aortic dissections. In our
patient group, the dilated ascending aorta may inﬂuence the oc-
currence of retrograde type A dissection after TEVAR as
described in Table 2.
The principal aims of surgery for an acute type A dissection
by the conventional technique of replacement of the ascending
aorta and the aortic arch are to ensure the patient’s survival and
a low morbidity rate. The management of retrograde type A
aortic dissection after TEVAR has not been standardized yet.
Published reports focus on the treatment of retrograde type A
aortic dissection in the ascending aorta, aortic arch replacement,
or both, but do not address the lesion that develops into the
antegrade or retrograde component of the dissection. In cases
of type B aortic dissection, the site of the primary entry tear is
located in the descending aorta and cannot be effectively elimi-
nated by single replacement of the ascending aorta and the
aortic arch.
The single-stage hybrid approach implies conventional open
surgical treatment of the ascending aorta and the aortic arch
combined with open antegrade stent grafting of the proximal
descending aorta via a median sternotomy. A running suture
line at the offspring of the left subclavian artery ensures closure
of the primary lesion. The frozen elephant trunk technique thus
permits treatment of the underlying pathology in the proximal
descending aorta [22].
In summary, this single-stage hybrid approach permits safe, ef-
fective and simultaneous treatment of the ascending aorta, the
aortic arch and the descending aorta in patients with acute com-
plicated type B aortic dissection who undergo TEVAR and
develop retrograde type A dissection. The procedure is asso-
ciated with a good clinical outcome in patients with this poten-
tially lethal complication. Based on these ﬁndings, the frozen
elephant trunk procedure should be considered as a valuable
option in patients with acute complicated type B aortic dissec-
tion if associated with dilatation of the ascending aorta or pos-
sible potential components for retrograde type A dissection like
a short distance to the subclavian artery or the concavity of the
aortic arch as possible primary entry tear.
LIMITATIONS
Given the need for acute intervention in patients with compli-
cated type B aortic dissection following retrograde type A dissec-
tions after TEVAR, the present investigation was conducted as a
retrospective intention-to-treat analysis.
Although the patient population is small (n = 3), the results
support the thesis that retrograde type A aortic dissection can
be effectively treated by means of a combined surgical and
endovascular repair of the thoracic aorta. The small sample size
was due to the low incidence of this disease. Taking into
account the retrospective fashion of this study and the small
number of patients, the enlargement of the ascending aorta and
the short distance to the subclavian artery are the most notice-
able parameters in the case of retrograde dissection and should
be considered before stent graft implantation in type B dissec-
tions. A multi-centre study should be performed to conﬁrm
these ﬁndings. Besides, a prolonged follow-up period will help
to document the advantages of the method.
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APPENDIX. CONFERENCE DISCUSSION
Dr T. Schachner (Innsbruck, Austria): These results reported by you and the
group around Martin Grabenwöger are important, on the one hand to show
us the life-threatening character of complicated type B dissection and, on the
other hand, that this complication with retrograde dissection is perhaps
under-reported in the literature. My ﬁrst question is about bare springs. I re-
member a case I operated on six months ago where I clearly saw a bare
spring as a source of retrograde type A dissection following TEVAR. My ques-
tion is, did you or do you recommend the use of completely covered stent
grafts in this setting?
Dr Gortlitzer: This is a very interesting point regarding the causes of retro-
grade type A dissections. There are several publications describing that bare
springs induce retrograde type A dissections, and in our series, all cases with
retrograde type A dissections had stent grafts with uncovered bare springs. So I
think the industry at least should be advised to produce specially designed
stent grafts for the treatment of acute complicated type B dissections.
Dr Schachner: And did you undertake long-term follow-up of these
patients to ﬁnd out if there were perhaps cases of retrograde dissection that
contributed to late mortality or to a reoperation at another centre?
Dr Gorlitzer: Out of our 29 patients, we had a follow-up period of a
median 15 months, and we did not observe any late retrograde type A dis-
sections. That could be because the series is a little bit too small.
Dr Schachner: And my third question is about the interesting ﬁnding that
the dilated ascending aorta was a risk factor and, if I understood you correct-
ly, your ﬂow chart indicates that if you have an ascending aorta of 4 cm or
more, you go for a frozen elephant repair, including ascending, arch and des-
cending aortic replacement or repair. Is this true for all patients, or is this true
for patients with connective tissue disease?
Dr Gorlitzer: Based on our experiences, we have developed this ﬂow chart
which is generally applied wherever possible. If the ascending aorta is
enlarged, we assume that the whole aorta is sick and not only the descending
aorta. In cases with an enlarged ascending aorta, we perform the frozen ele-
phant technique.
Dr B. Zipfel (Berlin, Germany): I want to add a comment concerning the
bare stents. There is multicentre Registry data published in Circulation by
Dr. Eggebrecht from Essen, showing no clear correlation to the proximal
end of the stent grafts; this is also our experience. We have also seen per-
forations by the stent grafts as dissections remote from the stent grafts. So
the reason is not really clear, and it is hard to say that whether this com-
plication is related to a particular type of stent graft. As you pointed out,
this complication seems to be related mainly to type B dissection as a
primary indication. This ﬁnding is similar in the Registry data and also in
our own experience.
What is your strategy if you have an entry very close to the subclavian
artery or even involving the subclavian artery? In my experience, this seems
to have a higher risk for stent graft-associated Type A dissection. Would this
also be a reason for you to use the open stent graft technique?
Dr Gorlitzer: It is true that the distance to the subclavian artery inﬂuences
the outcome of the treatment with endovascular devices. Overall, the series
are too small to give guidelines or to develop a strategy depending on the
distances to the subclavian artery, so usually we over-cover the subclavian
artery.
Dr C. Etz (Leipzig, Germany): I would like you to speculate on the aetiology
again. What do you think is the role of oversizing? Do you have any data
regarding over-sized stent grafts or would that be something that you could
just give us your opinion on?
Dr Gorlitzer: Usually we do not oversize in type B dissections. If indicated,
we oversize to a maximum of 10% in acute type B dissections.
Dr Etz: So that could not be the reason for the retrograde type As?
Dr Gorlitzer: No.
Dr C. Mestres (Barcelona, Spain): I think you raised a very important
point with this contribution because, of course, there are so many things
that we do not know yet; this may require further elaboration. It is my
feeling that these anatomical factors that you mentioned (also mentioned
in one of the previous papers), such as the distance to the left subclavian
artery and the convexity and concavity, are going to play a very important
role at the time of decision-making. I think that regardless of the type of
disease, the problem is who treats those patients with complicated acute
type B dissection, which is, by deﬁnition, a surgical disease, but which is
managed by many other people who have no idea of surgery. This is one
of the problems. I think that the value of your contribution is that if more
information is collected in the future, it could be a major advance to go
back to surgery. It is likely that we have to prove it in the future because I
am absolutely sure that acute complicated type B dissection continues to
be a surgical disease that has to be managed by cardiothoracic and vascu-
lar surgeons rather than anybody else, and this is something that I encour-
age you to follow.
Dr Gorlitzer: I completely agree with you. This is a disease which has to be
managed by cardiac surgeons in a multidisciplinary setting.
Dr H. Jakob (Essen, Germany): I just want to ask you about the so-called ag-
gressive hemiarch, or as Martin Grabenwöger says, ‘arch light’. You leave in
diseased tissue. Have you ever seen problems later on after this kind of ap-
proach? I personally would prefer to be radical.
Dr Gorlitzer: Yes, I know. But we did not see any problems after leaving
the eyelet. We published this as a light arch replacement, and we did not
have any problems after this repair.
M. Gorlitzer et al. / European Journal of Cardio-Thoracic Surgery570
